Welcome to LookChem.com Sign In|Join Free

CAS

  • or

7115-24-4

Post Buying Request

7115-24-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • METHANESULFONIC ACID (4S,5S)-5-[(S)-((R)-2,2-DIMETHYL-[1,3]DIOXOLAN-4-YL)-METHANESULFONYLOXY-METHYL]-2,2-DIMETHYL-[1,3]DIOXOLAN-4-YLMETHYL ESTER

    Cas No: 7115-24-4

  • No Data

  • No Data

  • No Data

  • APAC Pharmaceutical, LLC
  • Contact Supplier

7115-24-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 7115-24-4 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 7,1,1 and 5 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 7115-24:
(6*7)+(5*1)+(4*1)+(3*5)+(2*2)+(1*4)=74
74 % 10 = 4
So 7115-24-4 is a valid CAS Registry Number.

7115-24-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name [(4S,5S)-5-[(S)-[(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]-methylsulfonyloxymethyl]-2,2-dimethyl-1,3-dioxolan-4-yl]methyl methanesulfonate

1.2 Other means of identification

Product number -
Other names METHANESULFONIC ACID (4S,5S)-5-[(S)-((R)-2,2-DIMETHYL-[1,3]DIOXOLAN-4-YL)-METHANESULFONYLOXY-METHYL]-2,2-DIMETHYL-[1,3]DIOXOLAN-4-YLMETHYL ESTER

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:7115-24-4 SDS

7115-24-4Relevant articles and documents

Synthesis and antioxidant capacity of novel stable 5-tellurofuranose derivatives

Borges, Elton L.,Ignasiak, Marta T.,Velichenko, Yuliia,Perin, Gelson,Hutton, Craig A.,Davies, Michael J.,Schiesser, Carl H.

, p. 2990 - 2993 (2018)

Novel stable tellurium-containing carbohydrate derivatives are prepared from hexitols and pentitols through a double nucleophilic substitution with NaHTe in PEG-400. These tellurosugars react at very high rates with two-electron oxidants, including hypochlorous and peroxynitrous acid, formed at sites of inflammation, and show considerable promise as protective agents against oxidative damage.

Discovery and Structure-Activity Relationships of Novel Template, Truncated 1′-Homologated Adenosine Derivatives as Pure Dual PPARγ/δModulators

An, Seungchan,Kim, Gyudong,Kim, Hyun Jin,Ahn, Sungjin,Kim, Hyun Young,Ko, Hyejin,Hyun, Young Eum,Nguyen, Mai,Jeong, Juri,Liu, Zijing,Han, Jinhe,Choi, Hongseok,Yu, Jinha,Kim, Ji Won,Lee, Hyuk Woo,Jacobson, Kenneth A.,Cho, Won Jea,Kim, Young-Mi,Kang, Keon Wook,Noh, Minsoo,Jeong, Lak Shin

, p. 16012 - 16027 (2021/01/09)

Following our report that A3 adenosine receptor (AR) antagonist 1 exhibited a polypharmacological profile as a dual modulator of peroxisome proliferator-activated receptor (PPAR)γ/δ, we discovered a new template, 1′-homologated adenosine analogues 4a-4t, as dual PPARγ/δmodulators without AR binding. Removal of binding affinity to A3AR was achieved by 1′-homologation, and PPARγ/δdual modulation was derived from the structural similarity between the target nucleosides and PPAR modulator drug, rosiglitazone. All the final nucleosides were devoid of AR-binding affinity and exhibited high binding affinities to PPARγ/δbut lacked PPARα binding. 2-Cl derivatives exhibited dual receptor-binding affinity to PPARγ/δ, which was absent for the corresponding 2-H derivatives. 2-Propynyl substitution prevented PPARδ-binding affinity but preserved PPARγaffinity, indicating that the C2 position defines a pharmacophore for selective PPARγligand designs. PPARγ/δdual modulators functioning as both PPARγpartial agonists and PPARδantagonists promoted adiponectin production, suggesting their therapeutic potential against hypoadiponectinemia-associated cancer and metabolic diseases.

Correlation study between A3 adenosine receptor binding affinity and anti-renal interstitial fibrosis activity of truncated adenosine derivatives

Yu, Jinha,Kim, Gyudong,Jarhad, Dnyandev B.,Lee, Hyuk Woo,Lee, Jiyoun,Park, Chong Woo,Ha, Hunjoo,Jeong, Lak Shin

, p. 773 - 779 (2018/10/09)

Truncated 4′-thionucleosides 1–4 and 4′-oxonucleosides 5–8 as potent and selective A3AR antagonists were synthesized from d-mannose and d-erythronic acid γ-lactone, respectively. These nucleosides were evaluated for their anti-fibrotic renoprot

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 7115-24-4